Roche Holding AG Inh.-Genuß.(Sp.ADRs) 1/8/SF100
- BID
44.8
- ASK
44.978
- 446 Units700 Units
- 07/21, 21:59:59 PM
Sector and Industry
Healthcare, Biopharmaceuticals
Performance (1Y)
30.69%
Market Cap
246.91 Bil.
P/E Ratio
21.17
Dividend Yield
1.94 %
Earnings per Share
2.16 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| Eli Lilly and Company | 864.54 Bil. | 57.78 Bil. | 46.82 | +86.88 % | 0.00 | - |
| Johnson & Johnson | 425.70 Bil. | 83.48 Bil. | 18.82 | +82.71 % | 0.00 | - |
| AbbVie Inc. | 343.94 Bil. | 54.21 Bil. | 96.78 | -5.29 % | 0.00 | - |
| Roche Holding AG | 286.62 Bil. | 65.80 Bil. | 20.72 | +58.45 % | 0.00 | - |
| AstraZeneca PLC | 244.91 Bil. | 52.09 Bil. | 27.55 | +39.41 % | 0.00 | - |
| NOVARTIS AG | 224.76 Bil. | 48.44 Bil. | 18.30 | +12.45 % | 0.00 | - |
| Merck & Co. Inc. | 221.79 Bil. | 57.55 Bil. | 14.46 | +2.25 % | 0.00 | - |
| Novo-Nordisk AS B | 193.52 Bil. | 41.49 Bil. | 14.11 | +1.54 % | 0.00 | - |
| Amgen Inc. | 150.16 Bil. | 32.57 Bil. | 23.01 | +80.77 % | 0.00 | - |
| Gilead Sciences Inc. | 129.70 Bil. | 26.10 Bil. | 18.10 | +1,599.93 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 44.8 G | 0 Units |
| PRICE DETERMINATION TIME | 07/21/2026 / 09:57:13 PM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 45 | 44.397 |
| PREV. DAY'S PRICE | 44.5 | (07/20) |
| CHANGE DAY BEFORE | +0.30 | 0.67 % |
| 52 WEEK HIGH / LOW | 51.5 (02/24) | 32.16 (08/12) |
Key Figures (in EUR)
| 2023 | 2024 | 2025 | 2026e | 2027e | |
|---|---|---|---|---|---|
EARNINGS PER SHARE | 1.85 | 1.36 | 2.16 | 2.76 | 2.97 |
DIVIDENDS PER SHARE | 0.78 | 0.79 | 0.89 | - | - |
DIVIDEND YIELD IN % | 2.34 % | 2.45 % | 1.94 % | - | - |
DIVIDEND GROWTH IN % | 2.79 % | 0.99 % | 12.10 % | - | - |
PRICE - EARNINGS RATIO | 18.10 | 23.66 | 21.17 | 16.38 | 15.22 |
PRICE - BOOK RATIO | 6.63 | 6.33 | 7.69 | - | - |
PRICE - SALES RATIO | 3.57 | 3.26 | 4.47 | - | - |
PRICE - CASH FLOW RATIO | 13.52 | 10.27 | 15.43 | - | - |
Master Data
| WKN | 891106 |
| ISIN | US7711951043 |
| SYMBOL | RHO6 |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | Roche ADR |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | US Dollar |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Biopharmaceuticals |
| NUMBER OF SHARES | 5.51 Bil. |
| MARKET CAPITALISATION | 246.91 Bil. |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | 0.23 % | 2.09 % | 2.03 % | -3.92 % | 30.69 % | 26.69 % | 9.61 % | 2.66 % |
| HIGH | 45.39 | 46.60 | 46.60 | 51.50 | 51.50 | 51.50 | 51.50 | 51.50 |
| LOW | 43.60 | 42.60 | 41.80 | 40.50 | 32.16 | 27.10 | 27.10 | 40.50 |
Dividende
pro Aktie
Company profile
Roche Holding AG is a research healthcare company. It operates through the Roche Pharmaceuticals and Diagnostics segments. The Roche Pharmaceutical division comprises the business segments, such as Roche Pharmaceuticals and Chuga. The Diagnostic division consists of the following four business areas: centralized and point of care solutions, molecular diagnostics, tissue diagnostics, and diabetes care. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.